Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Por um escritor misterioso
Descrição
Novel peptide nanoparticle–biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness - ScienceDirect
Targeting lung inflammation: novel therapies for the treatment of COPD. - Abstract - Europe PMC
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+ T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
Structural Analysis of Chemokine Receptor-Ligand Interactions. - Abstract - Europe PMC
Structural Analysis of Chemokine Receptor–Ligand Interactions
Recent updates for designing CCR5 antagonists as anti-retroviral agents - ScienceDirect
Lihu Yang's research works Merck & Co., Whitehouse Station (MSD) and other places
Malcolm MacCoss's research works Merck & Co., Whitehouse Station (MSD) and other places
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics
Structural Analysis of Chemokine Receptor-Ligand Interactions. - Abstract - Europe PMC
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
Sander G Mills's research works Merck & Co., Whitehouse Station (MSD) and other places
Sander G Mills's research works Merck & Co., Whitehouse Station (MSD) and other places
Full article: Chemokine receptor antagonists: Part 1
de
por adulto (o preço varia de acordo com o tamanho do grupo)
